No photo of Peter Cole

View Scopus Profile

Peter Cole

  • 1231 Citations
  • 20 h-Index
19982023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Peter Cole is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Precursor Cell Lymphoblastic Leukemia-Lymphoma Medicine & Life Sciences
Methotrexate Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
gemcitabine Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Folic Acid Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2023

Identifying children with subclinical neurocognitive decline and susceptibility to oxidative damage during the early months of therapy for ALL

Cole, P. & Sands, S. A.

National Institutes of Health

9/17/18 → 8/31/23

Project: Research project

Secondary Prevention
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Therapeutics
Oxidative Stress
Cognition

Pathophysiology of Chemotherapy-Induced Cognitive Deficits in Juvenile Rats

Cole, P.

National Institutes of Health

6/1/14 → 6/30/20

Project: Research project

Methotrexate
Drug Therapy
Leukemia
Homocysteine
Folic Acid

Markers of Cognitive Decline During Treatment for Childhood ALL

Cole, P. & Sands, S. A.

National Institutes of Health

9/17/15 → 6/30/18

Project: Research project

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Secondary Prevention
Cognition
Therapeutics
Leukemia

Research Output 1998 2019

2 Citations (Scopus)

Association of Combined Modality Therapy vs Chemotherapy Alone with Overall Survival in Early-Stage Pediatric Hodgkin Lymphoma

Jhawar, S. R., Rivera-Núñez, Z., Drachtman, R., Cole, P. D., Hoppe, B. S. & Parikh, R. R., May 2019, In : JAMA Oncology. 5, 5, p. 689-695 7 p.

Research output: Contribution to journal › Article

Combined Modality Therapy
Hodgkin Disease
Pediatrics
Drug Therapy
Survival

Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation

Brace, K. M., Lee, W. W., Cole, P. D. & Sussman, E. S., Sep 14 2019, In : Journal of Clinical and Experimental Neuropsychology. 41, 8, p. 814-831 18 p.

Research output: Contribution to journal › Article

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Evoked Potentials
Leukemia
Drug Therapy
Brain
1 Citation (Scopus)

Fluctuations in dietary intake during treatment for childhood leukemia: A report from the DALLT cohort

Ladas, E. J., Orjuela, M., Stevenson, K., Cole, P. D., Lin, M., Athale, U. H., Clavell, L. A., Leclerc, J. M., Laverdiere, C., Michon, B., Schorin, M. A., Welch, J. G., Asselin, B. L., Sallan, S. E., Silverman, L. B. & Kelly, K. M., Dec 2019, In : Clinical Nutrition. 38, 6, p. 2866-2874 9 p.

Research output: Contribution to journal › Article

Leukemia
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Nutrition Surveys
Pediatrics
Therapeutics

Pediatric hodgkin lymphoma: disparities in survival by race

Khullar, K., Rivera-Núñez, Z., Jhawar, S. R., Drachtman, R., Cole, P. D., Hoppe, B. S. & Parikh, R. R., Jan 1 2019, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journal › Article

Hodgkin Disease
Pediatrics
Survival
Proportional Hazards Models
Databases
1 Citation (Scopus)

Response-adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group

Kelly, K. M., Cole, P. D., Pei, Q., Bush, R., Roberts, K. B., Hodgson, D. C., McCarten, K. M., Cho, S. Y. & Schwartz, C., Oct 1 2019, In : British Journal of Haematology. 187, 1, p. 39-48 10 p.

Research output: Contribution to journal › Article

Hodgkin Disease
Positron-Emission Tomography
Confidence Intervals
Recurrence
Radiotherapy